Publications by authors named "Chan Kyu Sim"

Claim this Profile
R
Retained or altered expression of major histocompatibility complex class I in patient-derived xenograft models in breast cancer.
In Hye Song, Young-Ae Kim, Hyeonjin Lee, Hye Seon Park, In Ah Park, Chan Kyu Sim

Immunol Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Antitumor Immune Response in 2'-5' Oligoadenylate Synthetase-Like 1- (OASL1-) Deficient Mice upon Cisplatin Chemotherapy and Radiotherapy.
Chan Kyu Sim, Jung Hoon Lee, In-Jeoung Baek, Sang-Wook Lee, Myeong Sup Lee

J Immunol Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Compound Heterozygote Mutation in IL10RA in a Patient With Very Early-Onset Inflammatory Bowel Disease.
Seak Hee Oh, Young Hoon Sung, Inki Kim, Chan Kyu Sim, Jung Hoon Lee

Inflamm Bowel Dis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer.
Hee Jin Lee, Young-Ae Kim, Chan Kyu Sim, Sun-Hee Heo, In Hye Song

Oncotarget· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of IL-7 Expression Reporter Human Cell Lines, and Their Feasibility for High-Throughput Screening of IL-7-Upregulating Chemicals.
Yeon Sook Cho, Byung Soo Kim, Chan Kyu Sim, Inki Kim, Myeong Sup Lee

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2'-5' oligoadenylate synthetase-like 1 (OASL1) deficiency suppresses central nervous system damage in a murine MOG-induced multiple sclerosis model.
Bo Young Choi, Chan Kyu Sim, Yeon Sook Cho, Min Sohn, Young-Joon Kim

Neurosci Lett· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2'-5' Oligoadenylate synthetase-like 1 (OASL1) deficiency in mice promotes an effective anti-tumor immune response by enhancing the production of type I interferons.
Chan Kyu Sim, Yeon Sook Cho, Byung Soo Kim, In-Jeoung Baek, Young-Joon Kim

Cancer Immunol Immunother· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis